+Compare
ADMP
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
5.56M

ADMP Adamis Pharmaceuticals Corp Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for ADMP with price predictions
08:00 PM EDT Jun 01, 2023

ADMP in -25.27% downward trend, sliding for three consecutive days on May 26, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ADMP declined for three days, in of 362 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ADMP turned negative on May 19, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for ADMP entered a downward trend on June 02, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADMP advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADMP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.369) is normal, around the industry mean (42.146). P/E Ratio (0.000) is within average values for comparable stocks, (53.405). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.704). ADMP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.890) is also within normal values, averaging (54.597).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ADMP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Intra-Cellular Therapies (NASDAQ:ITCI), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.25B. The market cap for tickers in the group ranges from 246 to 76.71B. ZTS holds the highest valuation in this group at 76.71B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 35%. RMTI experienced the highest price growth at 77%, while ABTI experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -60%. For the same stocks of the Industry, the average monthly volume growth was -55% and the average quarterly volume growth was -99%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 50
SMR Rating: 85
Profit Risk Rating: 93
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11682 El Camino Real
Phone
+1 858 997-2400
Employees
12
Web
https://www.adamispharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNX92.222.90
+3.25%
TD SYNNEX Corp
DOMO13.430.41
+3.15%
Domo
ARCO8.830.10
+1.15%
Arcos Dorados Holdings
BCTX6.17-0.10
-1.59%
BriaCell Therapeutics Corp
NBRV1.46-0.17
-10.43%
Nabriva Therapeutics plc

ADMP and

Correlation & Price change

A.I.dvisor tells us that ADMP and SNDL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADMP and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMP
1D Price
Change %
ADMP100%
-0.96%
SNDL - ADMP
21%
Poorly correlated
+2.07%
CLVR - ADMP
21%
Poorly correlated
+6.73%
ZOM - ADMP
21%
Poorly correlated
-1.26%
DVAX - ADMP
20%
Poorly correlated
+1.57%
HCM - ADMP
20%
Poorly correlated
+3.05%
More

Groups containing ADMP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMP
1D Price
Change %
ADMP100%
-0.96%
pharmaceuticals
(undefined stocks)
9%
Poorly correlated
+1.29%
Pharmaceuticals
(undefined stocks)
5%
Poorly correlated
+0.44%
Pharmaceuticals: Other
(undefined stocks)
5%
Poorly correlated
+0.40%